AiBIOLOGICS is a biotechnology company which has developed AI and deep learning algorithms (EpitopePredikt) designed to assist in the fields of antibody discovery, diagnostic research, immunoassay development and vaccine development. Our EpitopePredikt software is capable of identifying immunodominant sequences within any protein from any species. In addition to this EpitopePredikt can identify the most likely antibody class or subtype to respond to the epitope. EpitopePredikt along with our novel immunoassay raw materials, antigens, immunogens, antibodies and vaccine subunits offers groundbreaking advancements to our customers. Our areas of expertise include antibody discovery, diagnostic research, immunoassay development, and vaccine development. If you have a current project in one of these fields and would like to see how AiBIOLOGICS technology can assist and advance your development, please contact us.